Cargando…
Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity
Tumor vasculature abnormality creates a microenvironment that is not suitable for anti-tumor immune response and thereby induces resistance to immunotherapy. Remodeling of dysfunctional tumor blood vessels by anti-angiogenic approaches, known as vascular normalization, reshapes the tumor microenviro...
Autores principales: | Tzeng, Hong-Tai, Huang, Yu-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002465/ https://www.ncbi.nlm.nih.gov/pubmed/36901858 http://dx.doi.org/10.3390/ijms24054422 |
Ejemplares similares
-
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
por: Berdel, Andrew F., et al.
Publicado: (2021) -
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
por: Wagner, Samuel C., et al.
Publicado: (2015) -
Anti-tumor pharmacology of natural products targeting mitosis
por: Huang, Manru, et al.
Publicado: (2022) -
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018) -
Neuropilins in the Context of Tumor Vasculature
por: Niland, Stephan, et al.
Publicado: (2019)